Stanford Cancer Institute Breakthroughs in Cancer: Jennifer Wargo, MD, MMSc

Topic: Targeting the Tissue Microenvironment and Microbiome to Promote Health and End Cancer
Jennifer Wargo is a surgeon-scientist and endowed professor of surgical oncology and genomic medicine at MD Anderson Cancer Center. She is a leader in translational studies to understand how interactions between targeted therapy, immunotherapy, and the microbiome influence tumor responses and resistance in melanoma and other cancers.
Breakthroughs in Cancer seminar series is one of the highest-profile seminar series for translational and clinical scientists in oncology. The series brings national leaders in cancer research to Stanford’s campus and highlights innovations across the spectrum of basic, translational, clinical, and population science.
#oncology #cancerresearch #sciencemedicine
Learn more about our Breakthroughs in Cancer seminar series: med.stanford.edu/cancer/train...
Learn more about the Stanford Cancer Institute:
med.stanford.edu/cancer
Follow the Stanford Cancer Institute LinkedIn: / stanford-cancer
Twitter: / scidirector
Subscribe to the Stanford Cancer Institute: / @stanfordcancerinstitute